Targeted deletion of BCL11A gene by CRISPR-Cas9 system for fetal hemoglobin reactivation: A promising approach for gene therapy of beta thalassemia disease
Mohammad Khosravi(Delft University of Technology), Morteza Karimipoor(Pasteur Institute of Iran)
Cited by 68